Former JnJ executive Marianne De Backer to lead Bayer pharma division Medical Dialogues Bureau4 Sep 2019 4:00 AM GMTMarianne De Backer will take the role of Head of Business Development & Licensing at Bayer's pharmaceuticals division, joining from rival JnJ,...
Bayer buys BlueRock in USD 600 million bet on stem cell therapies Medical Dialogues Bureau9 Aug 2019 3:30 AM GMTFRANKFURT: German drugmaker Bayer is paying up to $600 million for full control of cell therapy developer BlueRock Therapeutics, stepping up...